News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
329,456 Results
Type
Article (26418)
Company Profile (146)
Press Release (302892)
Multimedia
Podcasts (30)
Webinars (11)
Section
Business (94328)
Career Advice (1310)
Deals (14532)
Drug Delivery (80)
Drug Development (38478)
Employer Resources (155)
FDA (8039)
Job Trends (8654)
News (156841)
Policy (13787)
Tag
Academia (1978)
Academic (2)
Accelerated approval (3)
Adcomms (17)
Allergies (76)
Alliances (25367)
ALS (70)
Alzheimer's disease (855)
Antibody-drug conjugate (ADC) (75)
Approvals (8089)
Artificial intelligence (179)
Autoimmune disease (13)
Automation (12)
Bankruptcy (97)
Best Places to Work (7414)
BIOSECURE Act (13)
Biosimilars (67)
Biotechnology (90)
Bladder cancer (56)
Brain cancer (17)
Breast cancer (165)
Cancer (1231)
Cardiovascular disease (108)
Career advice (1155)
Career pathing (33)
CAR-T (91)
Cell therapy (260)
Cervical cancer (13)
Clinical research (31460)
Collaboration (545)
Compensation (211)
Complete response letters (12)
COVID-19 (1329)
CRISPR (31)
C-suite (178)
Cystic fibrosis (82)
Data (1451)
Decentralized trials (1)
Denatured (21)
Depression (29)
Diabetes (167)
Diagnostics (3409)
Digital health (7)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (73)
Drug pricing (61)
Drug shortages (5)
Duchenne muscular dystrophy (64)
Earnings (29613)
Editorial (18)
Employer branding (24)
Employer resources (134)
Events (49519)
Executive appointments (532)
FDA (8966)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (513)
Gene editing (73)
Generative AI (16)
Gene therapy (217)
GLP-1 (399)
Government (2427)
Grass and pollen (2)
Guidances (87)
Healthcare (10013)
Huntington's disease (16)
IgA nephropathy (20)
Immunology and inflammation (51)
Indications (16)
Infectious disease (1418)
Inflammatory bowel disease (107)
Inflation Reduction Act (8)
Influenza (29)
Intellectual property (52)
Interviews (196)
IPO (6692)
IRA (23)
Job creations (1580)
Job search strategy (1007)
Kidney cancer (2)
Labor market (39)
Layoffs (191)
Leadership (16)
Legal (2186)
Liver cancer (42)
Lung cancer (169)
Lymphoma (96)
Machine learning (4)
Management (52)
Manufacturing (185)
MASH (31)
Medical device (6484)
Medtech (6488)
Mergers & acquisitions (8211)
Metabolic disorders (387)
Multiple sclerosis (52)
NASH (11)
Neurodegenerative disease (47)
Neuropsychiatric disorders (7)
Neuroscience (1218)
NextGen: Class of 2025 (3702)
Non-profit (3461)
Now hiring (39)
Obesity (194)
Opinion (129)
Ovarian cancer (47)
Pain (59)
Pancreatic cancer (44)
Parkinson's disease (102)
Partnered (14)
Patents (112)
Patient recruitment (67)
Peanut (42)
People (33727)
Pharmaceutical (41)
Pharmacy benefit managers (4)
Phase I (9079)
Phase II (13571)
Phase III (11669)
Pipeline (772)
Policy (70)
Postmarket research (1241)
Preclinical (3972)
Press Release (61)
Prostate cancer (61)
Psychedelics (18)
Radiopharmaceuticals (124)
Rare diseases (283)
Real estate (3208)
Recruiting (59)
Regulatory (10410)
Reports (44)
Research institute (1730)
Resumes & cover letters (165)
Rett syndrome (5)
RNA editing (2)
RSV (32)
Schizophrenia (48)
Series A (94)
Series B (57)
Service/supplier (8)
Sickle cell disease (40)
Special edition (8)
Spinal muscular atrophy (108)
Sponsored (24)
Startups (2372)
State (1)
Stomach cancer (8)
Supply chain (29)
Tariffs (12)
The Weekly (9)
Vaccines (326)
Venture capitalists (32)
Weight loss (119)
Women's health (16)
Worklife (18)
Date
Last 7 days (535)
Last 30 days (1702)
Last 365 days (18772)
2025 (6847)
2024 (20366)
2023 (22858)
2022 (28016)
2021 (31032)
2020 (28691)
2019 (25487)
2018 (18964)
2017 (16514)
2016 (15930)
2015 (17576)
2014 (12787)
2013 (10315)
2012 (10884)
2011 (11265)
2010 (10217)
Location
Africa (482)
Alabama (30)
Alaska (7)
Arizona (100)
Arkansas (9)
Asia (18883)
Australia (3405)
California (3590)
Canada (1052)
China (248)
Colorado (141)
Connecticut (176)
Delaware (119)
Europe (47091)
Florida (568)
Georgia (138)
Hawaii (1)
Idaho (23)
Illinois (287)
India (22)
Indiana (263)
Iowa (8)
Japan (138)
Kansas (47)
Kentucky (15)
Louisiana (8)
Maine (21)
Maryland (544)
Massachusetts (2744)
Michigan (132)
Minnesota (210)
Mississippi (2)
Missouri (47)
Montana (17)
Nebraska (10)
Nevada (44)
New Hampshire (20)
New Jersey (1138)
New Mexico (19)
New York (1060)
North Carolina (652)
North Dakota (8)
Northern California (1612)
Ohio (134)
Oklahoma (7)
Oregon (22)
Pennsylvania (772)
Puerto Rico (9)
Rhode Island (16)
South America (632)
South Carolina (10)
Southern California (1309)
Tennessee (45)
Texas (456)
United States (13671)
Utah (89)
Virginia (73)
Washington D.C. (43)
Washington State (246)
West Virginia (1)
Wisconsin (49)
329,456 Results for "454 life sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
·
1 min read
·
Lori Ellis
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
April 30, 2025
·
3 min read
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Compensation
Average Life Sciences Salaries Up 9% in 2024, but Bonuses and Equity Values Drop:
BioSpace
Report
The 9% average salary increase from 2023 to 2024 was the largest for life sciences professionals since 2021. Several factors could be behind the spike, including companies providing higher pay because bonuses and stock compensation went down.
March 25, 2025
·
3 min read
·
Angela Gabriel
Business
Philadelphia’s Life Sciences Scene Making Its Mark
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and Chamber of Commerce for Greater Philadelphia executives share why the area is a life sciences hot spot.
February 20, 2025
·
7 min read
·
Angela Gabriel
Job Trends
BioSpace
Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace
has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
·
1 min read
·
Chantal Dresner
Business
Chicago Area’s Life Sciences Scene Continues Making an Impression
While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical Consortium and COUR Pharmaceuticals executives share what makes the area a hot spot.
January 30, 2025
·
6 min read
·
Angela Gabriel
1 of 32,946
Next
